Arqit Quantum director and uniQure insider sell over $2 million in shares

Arqit Quantum director D'ovidio Manfredi Lefebvre sold 32,422 shares of the UK‑based quantum‑security firm on July 1 at an average price of $30.24, generating about $980,441 in proceeds. The same day he had sold 22,022 shares on June 30 at $30.07, raising roughly $662,202. Combined, the director disposed of more than $1.6 million worth of stock, reducing his holding by 0.74%.

Separately, uniQure N.V. insider Walid Abi‑Saab sold 30,000 shares of the Dutch gene‑therapy company on June 30 at $46.42 per share, netting approximately $1.39 million. The transaction, filed with the SEC under a pre‑arranged Rule 10b5‑1 trading plan, lowered his ownership by 16.83%. Both sales were disclosed in regulatory filings.

These insider transactions highlight ongoing share divestments by executives at publicly traded biotech and quantum‑technology firms.